A. Maity

发表

Combination of CHEK1/2 Inhibition and Ionizing Radiation Results in Abscopal Tumor Response through Increased Micronuclei Formation

H. Chao, Ilias V. Karagounis, Christoforos Thomas, 2020, Oncogene.

Potential molecular targets for manipulating the radiation response.

R. Muschel, A. Maity, W. Mckenna, 1997, International journal of radiation oncology, biology, physics.

Effects of ionizing radiation on cell cycle progression

R. Muschel, E. Bernhard, A. Maity, 1995, Radiation and environmental biophysics.

Radiation and Dual Checkpoint Blockade Activates Non-Redundant Immune Mechanisms in Cancer

H. Ishwaran, Kathleen D. Mansfield, E. Wherry, 2015, Nature.

The tumor microenvironment in non-small-cell lung cancer.

E. Graves, Q. Le, A. Maity, 2010, Seminars in radiation oncology.

Cell Cycle-dependent Regulation of the Cyclin B1 Promoter (*)

Ruth J. Muschel, Amit Maity, R. Muschel, 1995, The Journal of Biological Chemistry.

Near complete surgical resection predicts a favorable outcome in pediatric patients with nonbrainstem, malignant gliomas

Hui-Kuo G Shu, Amit Maity, Michael Fisher, 2004, Cancer.

Combining Radiation with Immunotherapy: The University of Pennsylvania Experience.

E. Wherry, A. Minn, A. Maity, 2020, Seminars in radiation oncology.

The effects of radiation on the expression of a newly cloned and characterized rat cyclin B mRNA.

R. Muschel, A. Maity, W. Mckenna, 1994, International journal of radiation oncology, biology, physics.

A Review of Radiation-Induced Coagulopathy and New Findings to Support Potential Prevention Strategies and Treatments

A. Maity, A. R. Kennedy, J. Sanzari, 2016, Radiation Research.

The Safety of Bridging Radiation with Anti-BCMA CAR T-Cell Therapy for Multiple Myeloma

B. Levine, C. June, A. Maity, 2021, Clinical Cancer Research.

Bridging Radiation Therapy Prior to Commercial Chimeric Antigen Receptor T-Cell Therapy for relapsed/refractory aggressive B-cell lymphoma.

Ying Xiao, A. Maity, J. Plastaras, 2020, International journal of radiation oncology, biology, physics.

The Future of Radiobiology.

Catherine C. Park, R. Bristow, Li Ma, 2018, Journal of the National Cancer Institute.

Management and outcomes of sinus histiocytosis with massive lymphadenopathy (Rosai Dorfman Disease)

A. Maity, J. Plastaras, E. Namoglu, 2019, Leukemia & lymphoma.

Evidence for post‐transcriptional regulation of cyclin B1 mRNA in the cell cycle and following irradiation in HeLa cells.

R. Muschel, A. Maity, W. Mckenna, 1995, The EMBO journal.

Detection of Reactive Oxygen Species via Endogenous Oxidative Pentose Phosphate Cycle Activity in Response to Oxygen Concentration

A. Maity, C. Koch, A. Kachur, 2007, Journal of Biological Chemistry.

Incident learning in pursuit of high reliability: implementing a comprehensive, low-threshold reporting program in a large, multisite radiation oncology department.

T. Solberg, S. Hahn, A. Maity, 2015, Joint Commission journal on quality and patient safety.

Cherenkov imaging for Total Skin Electron Therapy (TSET).

B. Pogue, Lei Dong, T. Zhu, 2019, Medical physics.

Increased expression of cyclin B1 mRNA coincides with diminished G2-phase arrest in irradiated HeLa cells treated with staurosporine or caffeine.

R. Muschel, E. Bernhard, A. Maity, 1994, Radiation research.

Regulation of glut1 mRNA by Hypoxia-inducible Factor-1

F. Ismail-Beigi, A. Maity, N. Pore, 2001, The Journal of Biological Chemistry.

Pulmonary function abnormalities in children treated with whole lung irradiation

A. Maity, J. Ginsberg, D. Weiner, 2006, Pediatric blood & cancer.

MODULATING THE TUMOR MICROENVIRONMENT TO IMPROVE RADIOTHERAPY

A. Maity, 2009, Retina.

A phase I study of nelfinavir concurrent with temozolomide and radiotherapy in patients with glioblastoma multiforme

S. Hahn, A. Maity, J. Dorsey, 2013, Journal of Neuro-Oncology.

Estrogen Receptor β-Mediated Inhibition of Actin-Based Cell Migration Suppresses Metastasis of Inflammatory Breast Cancer

Qi Long, R. Chakrabarti, S. Krishnamurthy, 2021, Cancer Research.

The implementation and assessment of a quality and safety culture education program in a large radiation oncology department.

S. Hahn, N. Vapiwala, A. Maity, 2016, Practical radiation oncology.

Childhood intracranial ependymoma

Michael Fisher, A. Maity, P. Phillips, 2007, Cancer.

Inhibition of Autophagy as a Strategy to Augment Radiosensitization by the Dual Phosphatidylinositol 3-Kinase/Mammalian Target of Rapamycin Inhibitor NVP-BEZ235

C. Koumenis, A. Maity, R. Rengan, 2012, Molecular Pharmacology.

Molecular Pathways: A Novel Approach to Targeting Hypoxia and Improving Radiotherapy Efficacy via Reduction in Oxygen Demand

A. Maity, A. Lin, 2015, Clinical Cancer Research.

Risk of pneumonitis and outcomes after mediastinal proton therapy for relapsed/refractory lymphoma: A PTCOG and PCG collaboration.

A. Maity, T. Yock, J. Plastaras, 2020, International journal of radiation oncology, biology, physics.

Association of antibiotic exposure with survival and toxicity in patients with melanoma receiving immunotherapy.

W. Xu, A. Facciabene, A. Maity, 2020, Journal of the National Cancer Institute.

M-CSF Signals through the MAPK/ERK Pathway via Sp1 to Induce VEGF Production and Induces Angiogenesis In Vivo

A. Maity, Yijie Wang, C. Marsh, 2008, PloS one.

Early Changes in Cardiovascular Biomarkers with Contemporary Thoracic Radiation Therapy for Breast Cancer, Lung Cancer, and Lymphoma.

C. Simone, S. Feigenberg, A. Maity, 2019, International journal of radiation oncology, biology, physics.

Decreased cyclin B1 expression contributes to G2 delay in human brain tumor cells after treatment with camptothecin.

R. Muschel, A. Maity, W. Mckenna, 2001, Neuro-oncology.

Inhibition of Autophagy as a Strategy to Augment Radiosensitization by the Dual PI3K/mTOR Inhibitor NVP-BEZ235

C. Koumenis, A. Maity, G. Cerniglia, 2012 .

Bortezomib sensitizes human head and neck carcinoma cells SQ20B to radiation

A. Maity, G. Cerniglia, Anjali K. Gupta, 2007, Cancer biology & therapy.

Moderate Colitis Not Requiring Intravenous Steroids Is Associated with Improved Survival in Stage IV Melanoma after Anti-CTLA4 Monotherapy, But Not Combination Therapy

A. Facciabene, A. Maity, L. Schuchter, 2022, The oncologist.

Proton Radiotherapy Following Chemotherapy in the Management of Aggressive Mediastinal non-Hodgkin Lymphomas: A PTCOG Lymphoma Subcommittee Collaboration

A. Maity, J. Plastaras, Michele M. Kim, 2022 .

Cyclin B1 availability is a rate-limiting component of the radiation-induced G2 delay in HeLa cells.

R. Muschel, A. Maity, W. Mckenna, 1997, Cancer research.

Delayed cyclin B1 expression during the G2 arrest following DNA damage.

R. Muschel, A. Maity, W. Mckenna, 1996, Oncogene.

The PI3K/Akt Pathway Regulates Oxygen Metabolism via Pyruvate Dehydrogenase (PDH)-E1a Phosphorylation

Shannon M. Gallagher-Colombo, S. Vinogradov, R. Sun, 2015 .

Factors associated with event reporting in the pediatric radiation oncology population using an electronic incident reporting system.

S. Hahn, A. Maity, P. Gabriel, 2015, Practical radiation oncology.

Design, Implementation, and in Vivo Validation of a Novel Proton FLASH Radiation Therapy System.

Lei Dong, J. Metz, K. Cengel, 2020, International journal of radiation oncology, biology, physics.

Low dose total body irradiation added to fludarabine and busulfan reduced intensity conditioning reduces graft failure in patients with myelofibrosis.

D. Porter, A. Maity, J. Plastaras, 2022, Transplantation and cellular therapy.

Radiation Therapy for Relapsed or Refractory Diffuse Large B-Cell Lymphoma: What Is the Right Regimen for Palliation?

A. Maity, J. Plastaras, A. Doucette, 2022, Advances in radiation oncology.

Comparison of FLASH Proton Entrance and the Spread-Out Bragg Peak Dose Regions in the Sparing of Mouse Intestinal Crypts and in a Pancreatic Tumor Model

Lei Dong, J. Metz, K. Cengel, 2021, Cancers.

Surgery with or without radiation therapy in the management of craniopharyngiomas in children and young adults.

L. Rorke, H. Shu, A. Maity, 2004, International journal of radiation oncology, biology, physics.

Effects of hyperbaric oxygen exposure on experimental head and neck tumor growth, oxygenation, and vasculature

S. Thom, E. Bernhard, A. Maity, 2005, Head & neck.

Palliative Radiotherapy for Diffuse Large B-cell Lymphoma.

A. Maity, J. Plastaras, M. Lariviere, 2021, Clinical lymphoma, myeloma & leukemia.

Craniospinal radiation in the treatment of biopsy-proven intracranial germinomas: twenty-five years' experience in a single center.

L. Rorke, H. Shu, A. Maity, 2004, International journal of radiation oncology, biology, physics.

Acute neurologic toxicity of palliative radiotherapy for brain metastases in patients receiving immune checkpoint blockade.

A. Maity, J. Plastaras, M. Alonso-Basanta, 2018, Neuro-oncology practice.

Molecular Neuroscience Review Article

A. Maity, F. Leuven, M. Fähling, 2011 .

Low-Dose Radiotherapy Versus Moderate-Dose Radiotherapy for the Treatment of Indolent Orbital Adnexal Lymphomas

A. Maity, J. Plastaras, E. Chong, 2021, Frontiers in Oncology.

Cancer of the Central Nervous System

John Y. K. Lee, K. Judy, A. Maity, 2020 .

Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade

H. Ishwaran, E. Wherry, A. Minn, 2016, Cell.

The molecular basis for cell cycle delays following ionizing radiation: a review.

R. Muschel, A. Maity, W. Mckenna, 1994, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Onset of mandible and tibia osteoradionecrosis: a comparative pilot study in the rat.

A. Wright, A. Maity, S. Both, 2013, Oral surgery, oral medicine, oral pathology and oral radiology.

Identification of putative c-Myc-responsive genes: characterization of rcl, a novel growth-related gene

C. Dang, A. Maity, Q. Li, 1997, Molecular and cellular biology.

Hypoxia and VEGF mRNA expression in human tumors.

A. Maity, C. Koch, S. Evans, 2001, Neoplasia.

PTEN mutation and epidermal growth factor receptor activation regulate vascular endothelial growth factor (VEGF) mRNA expression in human glioblastoma cells by transactivating the proximal VEGF promoter.

Amit Maity, D. O’Rourke, A. Maity, 2003, Cancer research.

Modulating the tumor microenvironment to increase radiation responsiveness

A. Maity, J. Karar, 2009, Cancer biology & therapy.

Cellular responses to EGFR inhibitors and their relevance to cancer therapy.

A. Maity, P. Dutta, 2007, Cancer letters.

In vivo profiling of hypoxic gene expression in gliomas using the hypoxia marker EF5 and laser-capture microdissection.

A. Hatzigeorgiou, P. Alexiou, J. Tobias, 2011, Cancer research.

Plasma D-Dimer Levels are Elevated in Radiation Oncology Patients

A. Maity, N. Louneva, A. Kennedy, 2019, Radiation Research.

ER stress-mediated autophagy promotes Myc-dependent transformation and tumor growth.

I. Mills, A. Koong, D. Ruggero, 2012, The Journal of clinical investigation.

Temporal DNA-PK activation drives genomic instability and therapy resistance in glioma stem cells.

Lin Zhang, C. Koumenis, A. Maity, 2018, JCI insight.

Results Time-dependent radioresistance is associated with delayed H 2 AX phosphorylation and DNA repair after radiation in CSCs

Lin Zhang, C. Koumenis, A. Maity, 2018 .

Akt1 Activation Can Augment Hypoxia-Inducible Factor-1α Expression by Increasing Protein Translation through a Mammalian Target of Rapamycin–Independent Pathway

E. Bernhard, A. Maity, G. Kao, 2006, Molecular Cancer Research.

The PI3K/Akt Pathway Regulates Oxygen Metabolism via Pyruvate Dehydrogenase (PDH)-E1α Phosphorylation

Shannon M. Gallagher-Colombo, S. Vinogradov, R. Sun, 2015, Molecular Cancer Therapeutics.

The PI 3 K / Akt Pathway Regulates Oxygen Metabolism via Pyruvate Dehydrogenase ( PDH )-E 1 a Phosphorylation

Shannon M. Gallagher-Colombo, S. Vinogradov, R. Sun, 2015 .

HIF and MIF--a nifty way to delay senescence?

C. Koumenis, A. Maity, 2006, Genes & development.

Regulation of radiation-induced apoptosis in oncogene-transfected fibroblasts: influence of H-ras on the G2 delay.

R. Muschel, E. Bernhard, A. Maity, 1996, Oncogene.

Mediastinal masses in children with Hodgkin's disease. An analysis of the Children's hospital of philadelphia and the hospital of the university of pennsylvania experience

A. Maity, B. Lange, J. Goldwein, 1992, Cancer.

Sirolimus as a potential radiosensitizer in squamous cell cancer of the head and neck

A. Maity, R. Lustig, E. Shinohara, 2009, Head & neck.

Dual PI3K/mTOR inhibitor NVP-BEZ235 suppresses hypoxia-inducible factor (HIF)-1α expression by blocking protein translation and increases cell death under hypoxia

C. Koumenis, A. Maity, G. Cerniglia, 2012, Cancer biology & therapy.

Sp1 is involved in Akt-mediated induction of VEGF expression through an HIF-1-independent mechanism.

D. O’Rourke, D. Stokoe, G. Pagès, 2004, Molecular biology of the cell.

Phosphatase and tensin homologue deficiency in glioblastoma confers resistance to radiation and temozolomide that is reversed by the protease inhibitor nelfinavir.

S. Hahn, E. Bernhard, A. Maity, 2007, Cancer research.

The HIV protease inhibitor nelfinavir downregulates Akt phosphorylation by inhibiting proteasomal activity and inducing the unfolded protein response.

S. Hahn, A. Maity, G. Cerniglia, 2007, Neoplasia.

HIV protease inhibitors decrease VEGF/HIF-1alpha expression and angiogenesis in glioblastoma cells.

A. Maity, G. Cerniglia, Anjali K. Gupta, 2006, Neoplasia.

Nelfinavir down-regulates hypoxia-inducible factor 1alpha and VEGF expression and increases tumor oxygenation: implications for radiotherapy.

S. Hahn, E. Bernhard, A. Maity, 2006, Cancer research.

A stratified phase I dose escalation trial of hypofractionated radiotherapy followed by ipilimumab in metastatic melanoma: long-term follow-up and final outcomes

A. Minn, A. Maity, R. Mick, 2021, Oncoimmunology.

Radiotherapy and the tumor microenvironment: mutual influence and clinical implications.

Reid F Thompson, A. Maity, 2014, Advances in experimental medicine and biology.

Aiding and ABT’ing treatment for glioblastoma

A. Maity, A. Thomas-Tikhonenko, M. Dews, 2007, Cancer biology & therapy.

Epidermal growth factor receptor transcriptionally up-regulates vascular endothelial growth factor expression in human glioblastoma cells via a pathway involving phosphatidylinositol 3'-kinase and distinct from that induced by hypoxia.

D. O’Rourke, A. Maity, D. Solomon, 2000, Cancer research.

Epidermal Growth Factor Receptor Transcriptionally UpRegulates Vascular Endothelial Growth Factor Expression in Human Glioblastoma Cells via a Pathway Involving Phosphatidylinositol 3 *-Kinase and Distinct from That Induced by Hypoxia 1

D. O’Rourke, A. Maity, D. Solomon, 2000 .

EGFR tyrosine kinase inhibitors decrease VEGF expression by both hypoxia-inducible factor (HIF)-1-independent and HIF-1-dependent mechanisms.

A. Maity, G. Kao, G. Cerniglia, 2006, Cancer research.

Low pO2 and β-Estradiol Induce VEGF in MCF-7 and MCF-7-5C Cells: Relationship to in vivo Hypoxia

A. Maity, C. Koch, S. Evans, 2001, Breast Cancer Research and Treatment.

Phase 1 trial of nelfinavir added to standard cisplatin chemotherapy with concurrent pelvic radiation for locally advanced cervical cancer

G. Mills, A. Maity, A. Kossenkov, 2021, Cancer.

Clinical Outcomes of the HIV Protease Inhibitor Nelfinavir With Concurrent Chemoradiotherapy for Unresectable Stage IIIA/IIIB Non-Small Cell Lung Cancer: A Phase 1/2 Trial.

C. Simone, S. Hahn, A. Maity, 2019, JAMA oncology.

A phase I trial of pembrolizumab with hypofractionated radiotherapy in patients with metastatic solid tumours

E. Wherry, A. DeMichele, A. Minn, 2018, British Journal of Cancer.

Transcriptome analysis of hypoxic cancer cells uncovers intron retention in EIF2B5 as a mechanism to inhibit translation

M. Ivan, C. Ivan, C. Koumenis, 2017, PLoS biology.

Ionizing radiation inhibits tumor neovascularization by inducing ineffective angiogenesis

C. Sehgal, M. Feldman, A. Maity, 2005, Cancer biology & therapy.

Both increased stability and transcription contribute to the induction of the urokinase plasminogen activator receptor (uPAR) message by hypoxia.

A. Maity, D. Solomon, 2000, Experimental cell research.

Regulation of histone deacetylase 4 expression by the SP family of transcription factors.

A. Maity, G. Kao, M. Dowling, 2005, Molecular biology of the cell.

Regulation of histone deacetylase 4 ( HDAC 4 ) expression by the SP family of transcription factors

A. Maity, G. Kao, M. Dowling, 2005 .

Increasing sensitivity to radiotherapy and chemotherapy by using novel biological agents that alter the tumor microenvironment.

A. Maity, E. Shinohara, E T Shinohara, 2009, Current molecular medicine.

Brentuximab vedotin in combination with rituximab, cyclophosphamide, doxorubicin, and prednisone as frontline treatment for patients with CD30-positive B-cell lymphomas

C. Steidl, M. Lim, A. Maity, 2020, Haematologica.

Tolerability of sequential immune therapy and palliative radiotherapy to the cervical and thoracic spine

A. Maity, J. Plastaras, A. Doucette, 2018, Journal of Radiation Oncology.

Treatment of Pediatric Intracranial Arteriovenous Malformations with Linear-Accelerator-Based Stereotactic Radiosurgery: The University of Pennsylvania Experience

H. Shu, A. Maity, R. Lustig, 2004, Pediatric Neurosurgery.

HIV Protease Inhibitors Decrease VEGF / HIF-1 A Expression and Angiogenesis in Glioblastoma Cells 1

A. Maity, G. Cerniglia, Anjali K. Gupta, 2006 .

A Characterization of Bridging Therapies Leading up to Commercial CAR T-Cell Therapy

D. Porter, A. Maity, J. Plastaras, 2019, Blood.

Awakening the immune system with radiation: Optimal dose and fractionation.

Stephen M Hahn, E John Wherry, Saumil J Gandhi, 2015, Cancer letters.

Low-Dose Total Skin Electron Beam Therapy as Part of a Multimodality Regimen for Treatment of Sézary Syndrome: Clinical, Immunologic, and Molecular Analysis.

Sara A. Berg, R. Clark, A. Maity, 2020, JAMA dermatology.

Transient expansion and myofibroblast conversion of adipogenic lineage precursors mediate bone marrow repair after radiation

Mingyao Li, K. Cengel, P. Seale, 2022, JCI insight.

Inhibition of Phosphatidylinositol-3-OH Kinase/Akt Signaling Impairs DNA Repair in Glioblastoma Cells following Ionizing Radiation*

A. Maity, G. Kao, Anjali K. Gupta, 2007, Journal of Biological Chemistry.

Modulating tumor vasculature through signaling inhibition to improve cytotoxic therapy.

E. Bernhard, A. Maity, 2010, Cancer research.

Journey Toward High Reliability: A Comprehensive Safety Program to Improve Quality of Care and Safety Culture in a Large, Multisite Radiation Oncology Department.

T. Solberg, S. Hahn, A. Maity, 2016, Journal of oncology practice.

Radiation response in two HPV-infected head-and-neck cancer cell lines in comparison to a non-HPV-infected cell line and relationship to signaling through AKT.

J. Buatti, H. Quon, A. Maity, 2009, International journal of radiation oncology, biology, physics.

Induction Radiation Prior to Commercial Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Non-Hodgkin Lymphoma

A. Maity, J. Plastaras, S. Schuster, 2019, International Journal of Radiation Oncology*Biology*Physics.

A phase I trial of pembrolizumab with hypofractionated radiotherapy in patients with metastatic solid tumours

E. Wherry, A. DeMichele, A. Minn, 2018, British Journal of Cancer.

New Strategies in Non–Small Cell Lung Cancer: Improving Outcomes in Chemoradiotherapy for Locally Advanced Disease

S. Hahn, A. Maity, R. Rengan, 2011, Clinical Cancer Research.

Alternate polyadenylation in rodent cells results in two differentially expressed cyclin B1 mRNAs.

R. Muschel, A. Maity, W. Mckenna, 1994, Biochemical and biophysical research communications.

A Phase I Trial of the HIV Protease Inhibitor Nelfinavir with Concurrent Chemoradiotherapy for Unresectable Stage IIIA/IIIB Non-small Cell Lung Cancer: A Report of Toxicities and Clinical Response

M. Rosen, S. Hahn, A. Maity, 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Epidermal Growth Factor Receptor Inhibition Modulates the Microenvironment by Vascular Normalization to Improve Chemotherapy and Radiotherapy Efficacy

Arjun G. Yodh, Chandra M. Sehgal, Regine Choe, 2009, PloS one.

Consolidative proton therapy after chemotherapy for patients with Hodgkin lymphoma

A. Maity, S. Flampouri, J. Plastaras, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Microenvironment and Immunology In Vivo Profiling of Hypoxic Gene Expression in Gliomas Using the Hypoxia Marker EF 5 and Laser-capture Microdissection

A. Hatzigeorgiou, P. Alexiou, J. Tobias, 2011 .

A phenomenological model of proton FLASH oxygen depletion effects depending on tissue vasculature and oxygen supply

J. Metz, Yingruo Fan, K. Cengel, 2022, Frontiers in Oncology.

FLASH Proton Radiotherapy Spares Normal Epithelial and Mesenchymal Tissues While Preserving Sarcoma Response

Gwendolyn M. Cramer, A. Hatzigeorgiou, J. Metz, 2021, Cancer Research.

Volumetric considerations in radiotherapy for pediatric parameningeal rhabdomyosarcomas.

H. Shu, A. Maity, J. Goldwein, 2003, International journal of radiation oncology, biology, physics.

Implications for Radiotherapy VEGF Expression and Increases Tumor Oxygenation : and α Nelfinavir Down-regulates Hypoxia-Inducible Factor 1

S. Hahn, E. Bernhard, A. Maity, 2006 .

Cherenkov imaging for total skin electron therapy: an evaluation of dose uniformity

Brian W. Pogue, Timothy C. Zhu, Petr Bruza, 2021, BiOS.

Cherenkov imaging for Total Skin Electron Therapy (TSET)

Brian W. Pogue, Timothy C. Zhu, Petr Bruza, 2018, BiOS.

Radiobiological effectiveness difference of proton arc beams versus conventional proton and photon beams

Noelle François, A. Maity, R. Dale, 2020, Physics in medicine and biology.

Consolidative Radiation Therapy Following Autologous Transplantation in Relapsed or Refractory Hodgkin Lymphoma

A. Maity, J. Plastaras, J. Lukens, 2015 .

The chemokine receptor CXCR4: A homing device for hypoxic cancer cells?

A. Maity, N. Pore, 2006, Cancer biology & therapy.

Radiation Therapy for Sarcomas

A. Maity, 2009 .

A multi‐institutional analysis of peritransplantation radiotherapy in patients with relapsed/refractory Hodgkin lymphoma undergoing autologous stem cell transplantation

Y. Oki, A. Maity, P. Allen, 2017, Cancer.

Evaluation of the cumulative Cherenkov converted dose on TSET patients with multiple Cherenkov cameras

B. Pogue, T. Zhu, A. Maity, 2023, BiOS.

Analysis of cumulative surface dose based on Cherenkov imaging of Total Skin Electron Therapy (TSET)

Yi Hong Ong, Timothy C. Zhu, Petr Bruza, 2019, BiOS.

Early Changes in Physical Activity and Quality of Life with Thoracic Radiation Therapy in Breast Cancer, Lung Cancer, and Lymphoma.

K. Cengel, S. Feigenberg, A. Berman, 2020, International journal of radiation oncology, biology, physics.

PI3K/AKT/mTOR Pathway in Angiogenesis

A. Maity, J. Karar, Amit Maity, 2011, Front. Mol. Neurosci..

First Clinical Report of Pencil Beam Scanned Proton Therapy for Mediastinal Lymphoma

A. Maity, J. Plastaras, S. Both, 2016 .

Bi-Institutional Report on Consolidative Proton Therapy after Initial Chemotherapy for Mediastinal Diffuse Large B-Cell and Primary Mediastinal Large B-Cell Lymphomas

A. Maity, S. Flampouri, J. Plastaras, 2018, International Journal of Radiation Oncology*Biology*Physics.

Oral Scientific SessionsRates of Toxicity and Outcomes After Mediastinal Proton Therapy For Relapsed/Refractory Lymphoma

A. Maity, S. Flampouri, J. Plastaras, 2017 .

Cyclin A message stability varies with the cell cycle.

R. Muschel, A. Maity, W. McKenna, 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

2-deoxy-glucose and radiation: Teaching an old DOG new tricks?

A. Maity, S. Tuttle, 2006, Cancer biology & therapy.

Galectin-1 and Immune Suppression during Radiotherapy

J. Welsh, S. Hahn, A. Maity, 2014, Clinical Cancer Research.

Framework for Quality Assurance of Ultra-High Dose Rate Clinical Trials Investigating FLASH Effects and Current Technology Gaps.

D. Gladstone, E. Moros, M. Surucu, 2023, International journal of radiation oncology, biology, physics.

Proton Radiation Therapy After Chemotherapy in the Management of Aggressive Mediastinal Non-Hodgkin Lymphomas: A Particle Therapy Cooperative Group Lymphoma Subcommittee Collaboration

A. Maity, J. Plastaras, Michele M. Kim, 2022, Advances in Radiation Oncology.

Journey Toward High Reliability: A Comprehensive Safety Program to Improve Quality of Care and Safety Culture in a Large, Multisite Radiation Oncology Department.

T. Solberg, S. Hahn, A. Maity, 2016, Journal of oncology practice.

Location, Location, Location-Makes All the Difference for Hypoxia in Lung Tumors

C. Koumenis, A. Maity, 2010, Clinical Cancer Research.

Testicular Seminoma 16 Years After Treatment for CNS Germinoma

H. Shu, A. Maity, A. Judkins, 2004, Journal of Neuro-Oncology.

growth-related gene . genes : characterization of rcl , a novel Identification of putative c-Myc-responsive

C. Dang, A. Maity, B. Lewis, 1997 .

A Single-Arm PHASE 2A Study of NM-IL-12 (rHu-IL12) in Patients with Mycosis Fungoides-Type CTCL (MF) Undergoing Low-Dose TOTAL Skin Electron BEAM Therapy (LD-TSEBT)

A. Maity, M. Khodadoust, A. Rook, 2016 .

Parkin Deficiency Suppresses Antigen Presentation to Promote Tumor Immune Evasion and Immunotherapy Resistance

A. Hatzigeorgiou, M. Lotze, A. Facciabene, 2023, Cancer research.